Trial NCT04327388; EudraCT2020-001162-12; U1111-1249-602
Publication Lescure FX, 2021 (quadruple blinding)
Dates: 3/28/2020 to 7/3/2020
Funding: Private (Sanofi and Regeneron Pharmaceuticals, Inc)
Conflict of interest: Yes